Sec. 2. Coverage at no cost sharing of COVID–19 vaccine and treatment under Medicaid program

1,354 words·~6 min read·/bill/116/s/4469/is/section-2

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 1905(a)(4) of the Social Security Act ( 42 U.S.C. 1396d(a)(4) ) is amended— by striking and

(D)and inserting

(D); and by striking the semicolon at the end and inserting ;

(E)during the portion of the emergency period described in paragraph (1)(B) of section 1135(g) beginning on the date of the enactment of the . COVID–19 Treatment Coverage Act , a COVID–19 vaccine licensed under section 351 of the Public Health Service Act, or approved or authorized under section 505 or 564 of the Federal Food, Drug, and Cosmetic Act, and administration of the vaccine;

(F)during such portion of the emergency period described in paragraph (1)(B) of section 1135(g), items or services for the prevention or treatment of COVID–19, including drugs approved or authorized under such section 505 or such section 564 or, without regard to the requirements of section 1902(a)(10)(B) (relating to comparability), in the case of an individual who is diagnosed with or presumed to have COVID–19, during such portion of such emergency period during which such individual is infected (or presumed infected) with COVID–19, the treatment of a condition that may complicate the treatment of COVID–19; Subsections (a)(2) and (b)(2) of section 1916 of the Social Security Act ( 42 U.S.C. 1396o ) are each amended— in subparagraph (F), by striking or at the end; in subparagraph (G), by striking ; and and inserting , or ; and by adding at the end the following subparagraphs: during the portion of the emergency period described in paragraph (1)(B) of section 1135(g) beginning on the date of the enactment of this subparagraph, a COVID–19 vaccine licensed under section 351 of the Public Health Service Act, or approved or authorized under section 505 or 564 of the Federal Food, Drug, and Cosmetic Act, and the administration of such vaccine, or during such portion of the emergency period described in paragraph (1)(B) of section 1135(g), any item or service furnished for the treatment of COVID–19, including drugs approved or authorized under such section 505 or such section 564 or, in the case of an individual who is diagnosed with or presumed to have COVID–19, during the portion of such emergency period during which such individual is infected (or presumed infected) with COVID–19, the treatment of a condition that may complicate the treatment of COVID–19; and . Section 1916A(b)(3)(B) of the Social Security Act ( 42 U.S.C. 1396o–1(b)(3)(B) ) is amended— in clause (xi), by striking any visit and inserting any service ; and by adding at the end the following clauses: During the portion of the emergency period described in paragraph (1)(B) of section 1135(g) beginning on the date of the enactment of this clause, a COVID–19 vaccine licensed under section 351 of the Public Health Service Act, or approved or authorized under section 505 or 564 of the Federal Food, Drug, and Cosmetic Act, and the administration of such vaccine. During such portion of the emergency period described in paragraph (1)(B) of section 1135(g), an item or service furnished for the treatment of COVID–19, including drugs approved or authorized under such section 505 or such section 564 or, in the case of an individual who is diagnosed with or presumed to have COVID–19, during such portion of such emergency period during which such individual is infected (or presumed infected) with COVID–19, the treatment of a condition that may complicate the treatment of COVID–19. . The amendments made by this subsection shall apply with respect to a State plan of a territory in the same manner as a State plan of one of the 50 States. Section 1928 of the Social Security Act ( 42 U.S.C. 1396s ) is amended— in subsection (a)(1)— in subparagraph (A), by striking ; and and inserting a semicolon; in subparagraph (B), by striking the period and inserting ; and ; and by adding at the end the following subparagraph: during the portion of the emergency period described in paragraph (1)(B) of section 1135(g) beginning on the date of the enactment of this subparagraph, each vaccine-eligible child (as defined in subsection (b)) is entitled to receive a COVID–19 vaccine from a program-registered provider (as defined in subsection (h)(7)) without charge for— the cost of such vaccine; or the administration of such vaccine. ; in subsection (c)(2)— in subparagraph (C)(ii), by inserting , but, during the portion of the emergency period described in paragraph (1)(B) of section 1135(g) beginning on the date of the enactment of the before the period; and COVID–19 Treatment Coverage Act , may not impose a fee for the administration of a COVID–19 vaccine by adding at the end the following subparagraph: The provider will provide and administer an approved COVID–19 vaccine to a vaccine-eligible child in accordance with the same requirements as apply under the preceding subparagraphs to the provision and administration of a qualified pediatric vaccine to such a child. ; and in subsection (d)(1), in the first sentence, by inserting , including, during the portion of the emergency period described in paragraph (1)(B) of section 1135(g) beginning on the date of the enactment of the before the period. COVID–19 Treatment Coverage Act , with respect to a COVID–19 vaccine licensed under section 351 of the Public Health Service Act, or approved or authorized under section 505 or 564 of the Federal Food, Drug, and Cosmetic Act Section 2103(c) of the Social Security Act ( 42 U.S.C. 1397cc(c) ) is amended by adding at the end the following paragraph: Regardless of the type of coverage elected by a State under subsection (a), child health assistance provided under such coverage for targeted low-income children and, in the case that the State elects to provide pregnancy-related assistance under such coverage pursuant to section 2112, such pregnancy-related assistance for targeted low-income pregnant women (as defined in section 2112(d)) shall include coverage, during the portion of the emergency period described in paragraph (1)(B) of section 1135(g) beginning on the date of the enactment of this paragraph, of— a COVID–19 vaccine licensed under section 351 of the Public Health Service Act, or approved or authorized under section 505 or 564 of the Federal Food, Drug, and Cosmetic Act, and the administration of such vaccine; and any item or service furnished for the treatment of COVID–19, including drugs approved or authorized under such section 505 or such section 564, or, in the case of an individual who is diagnosed with or presumed to have COVID–19, during the portion of such emergency period during which such individual is infected (or presumed infected) with COVID–19, the treatment of a condition that may complicate the treatment of COVID–19. . Section 2103(e)(2) of the Social Security Act ( 42 U.S.C. 1397cc(e)(2) ), as amended by section 6004(b)(3) of the Families First Coronavirus Response Act, is amended— in the paragraph header, by inserting before a COVID–19 vaccine, COVID–19 treatment, ; and or pregnancy-related assistance by striking visits described in section 1916(a)(2)(G), or and inserting services described in section 1916(a)(2)(G), vaccines described in section 1916(a)(2)(H) administered during the portion of the emergency period described in paragraph (1)(B) of section 1135(g) beginning on the date of the enactment of the . COVID–19 Treatment Coverage Act , items or services described in section 1916(a)(2)(I) furnished during such emergency period, or Section 1937 of the Social Security Act ( 42 U.S.C. 1396u–7 ) is amended— in subsection (a)(1)(B), by inserting , under subclause (XXIII) of section 1902(a)(10)(A)(ii), after section 1902(a)(10)(A)(i) ; and in subsection (b)(5), by adding before the period the following: , and, effective on the date of the enactment of the . COVID–19 Treatment Coverage Act , must comply with subparagraphs

(F)through

(I)of subsections (a)(2) and (b)(2) of section 1916 and subsection (b)(3)(B) of section 1916A The amendments made by this section shall take effect on the date of enactment of this Act and shall apply with respect to a COVID–19 vaccine beginning on the date that such vaccine is licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ), or approved or authorized under section 505 or 564 of the Federal Food, Drug, and Cosmetic Act.

Connectionstraces to 5

Traces to 5 documents

U.S. Code

2 references not yet in our index